Back
Innovator Intl Developed Power Buffer ETF - July Vs. Nektar Therapeutics Industry Stock Comparison
Buy
60
IJUL
Innovator Intl Developed Power Buffer ETF - July
Last Price:
$33.39
Seasonality Move:
-1.48%
Sell
39
NKTR
Nektar Therapeutics
Last Price:
$52.98
Seasonality Move:
11.58%
Buy
60
Innovator Intl Developed Power Buffer ETF - July (IJUL)
is a Buy
Is Innovator Intl Developed Power Buffer ETF - July a Buy, Sell or Hold?
-
The current Innovator Intl Developed Power Buffer ETF - July [IJUL] share price is $33.26. The Score for IJUL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
IJUL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IJUL Stock Price Chart
What is Innovator Intl Developed Power Buffer ETF - July's stock price today?
-
The Innovator Intl Developed Power Buffer ETF - July share price today is $33.26Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IJUL is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $54.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
IJUL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 62.92 | Buy |
| Chaikin Money Flow: | 3741 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.56 - 33.16) | Buy |
| Bollinger Bands (100): | (32.19 - 32.97) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 45.77 | Sell |
| Chaikin Money Flow: | 141668 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.71 - 61.07) | Sell |
| Bollinger Bands (100): | (32.74 - 62.56) | Buy |
IJUL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.11 | Buy |
| 20-day SMA: | 32.83 | Buy |
| 50-day SMA: | 32.84 | Buy |
| 200-day SMA: | 31.46 | Buy |
| 8-day EMA: | 33.12 | Buy |
| 20-day EMA: | 32.96 | Buy |
| 50-day EMA: | 32.12 | Buy |
| 200-day EMA: | 20.16 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.42 | Sell |
| 20-day SMA: | 58.12 | Sell |
| 50-day SMA: | 58.41 | Sell |
| 200-day SMA: | 30.65 | Buy |
| 8-day EMA: | 56.16 | Sell |
| 20-day EMA: | 57.43 | Sell |
| 50-day EMA: | 55.78 | Sell |
| 200-day EMA: | 37.86 | Buy |
Innovator Intl Developed Power Buffer ETF - July Earnings Growth & IJUL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
Innovator Intl Developed Power Buffer ETF - July Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||